DAFTAR PUSTAKA

1. Appe FS, Jafe AS . Cardiac Function. in Tietz Textbook of Clinical

Chemistry and Molecular Diagnostics. 4 th ed. Missouri: Elsevier
saunders ; 2006.
p. 1619 -1670
2. Appe FS, Jafe AS . Cardiovascular Disease. in Tietz Fundamentals of
Clinical Chemistry 6th ed. Missouri: Elsevier Saunders; 2008. p. 614 -
630
3. Sanhai WR, Ellof BC, Christenson RH. Cardiac and Muscle Disease. in
Clinical Chemistry Theory Analysis and Correlation 5 th ed. Missouri :
mosby Elsevier; 2010. p. 677- 690
4. Ganong WF. Physiology of Nerve & Muscle Cells. in Review of Medical
Physiology. 21 thed. New York: Lange Medical Books/McGraw-Hill Medical
Publishing Division ;2003. Section II.
5. Thygesen K, Alpert JS, White HD. Universal definition of myocardial
infarction. European Heart Journal. 2007; 28, 25252538
6. Bhatt DL, Flather MD. Handbook of Acute Coronary Syndromes 2 th ed.
London : Remedica Publishing ; 2004
7. Samsu N, Sargowo D. Tinjauan Pustaka Sensitivitas dan Spesifisitas
Troponin T dan I pada Diagnosis Infark Miokard Akut. Maj Kedokt Indon.
2007; Volum: 57, Nomor: 10, 363 -372
8. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE,
et al. ACC/AHA 2007 Guidelines for the Management of Patients With
Unstable Angina/Non_ST-Elevation Myocardial Infarction. Circulation.
2007;116:e148-e304.
9. Reichlin T, Hochholzer Wi, Bassetti S, Steuer S, Stelzig C, Hartwiger S,
et al. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac
Troponin Assays. N Engl J Med. 2009;361:858-67.
10. Babuin L, Jaffe AS. Troponin: the biomarker of choice for the
detection of cardiac injury . CMAJ. 2005;173(10):1191-202

1
11. Skeik N, Patel DC. A review of troponins in ischemic heart disease
and other conditions. Int J Angiol. Summer 2007 Vol 16 No 2.
12. Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MA. Role
of Monitoring Changes in Sensitive Cardiac Troponin I Assay Results for
Early Diagnosis of Myocardial Infarction and Prediction of Risk of
Adverse Events. Clinical Chemistry; 2009. 55:5. 930937
13. Kavsak PA, Xue SW, Ko DT, MacRae AR, Jaffe AS. Short- and Long-
Term Risk Stratification Using a Next-Generation, High-Sensitivity
Research CardiacTroponin I (hs-cTnI) Assay in an Emergency
Department Chest Pain Population. Clinical Chemistry. 2009; 55:10
18091815
14. AH Wu . Cardiac Markers 2 th ed. New Jersey : Humana Press Inc ;
2003
15. Melanson SE, Tanasijevic MJ, Jarolim P. Cardiac Troponin Assays: A
View From the Clinical Chemistry Laboratory. Circulation journal of
American Heart Association. 2007;116;e501-e504
16. Tate JR. Troponin revisited 2008: assay performance. Clin Chem
Lab Med. 2008;46(11):14891500
17. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of Cardiac
Troponin I Cutoff Concentrations below the 99th Percentile for Clinical
Decision-Making. Clinical Chemistry. 2009; 55:1 8592
18. Panteghini M, Bunk DM, Christenson RH, Katrukha A, Porter RA,
Schimmel H, et al. Standardization of troponin I measurements: an
update. Clin Chem Lab Med 2008;46(11):15011506
19. .Jeremias A, Gibson CM. Alternative Causes for Elevated Cardiac
Troponin Levels when Acute Coronary Syndromes Are Excluded. Ann
Intern Med. 2005;142:786-791
20. Comito, Sinatra R, Simon C, Capuano F, Roscitano A, Benedetto U,
et al. Cardiac Troponin I vs EuroSCORE: Myocardial Infarction and
Hospital Mortality. Asian Cardiovasc Thorac Ann. 2008;16:97-102

2
21. Jaffea AS, The clinical impact of the universal diagnosis of
myocardial infarction. Clin Chem Lab Med. 2008;46(11):14851488